Justyna Czarny

Dr. Justyna Czarny

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MLMagdalena Lange
Magdalena Lange
KHKarin Hartmann
Karin Hartmann
MCMelody C. Carter
Melody C. Carter
FSFrank Siebenhaar
Frank Siebenhaar
IÁIván Álvarez-Twose
Iván Álvarez-Twose
Peter ValentPeter Valent
Peter Valent
Pediatric mastocytosis is a heterogeneous disease characterized by accumulation of mast cells in the skin and less frequently in other organs. Somatic or germline mutations in the KIT proto-oncogene are detected in most patients. Cutaneous mastocytosis is the most common form of the disease in children. In the majority of cases, skin lesions regress spontaneously around puberty. However, in few patients, mastocytosis is not a self-limiting disease, but persists into adulthood and can show signs of systemic involvement, especially when skin lesions are small-sized and monomorphic. Children with mastocytosis often suffer from mast cell mediator-related symptoms. Severe hypersensitivity reactions can also occur, mostly in patients with extensive skin lesions and blistering. In a substantial number of these cases, the triggering factor of anaphylaxis remains unidentified. Management of pediatric mastocytosis is mainly based on strict avoidance of triggers, treatment with H1 and H2 histamine receptor blockers, and equipment of patients and their families with epinephrine auto-injectors for use in severe anaphylactic reactions. Advanced systemic mastocytosis occurs occasionally. All children with mastocytosis require follow-up examinations. A bone marrow investigation is performed when advanced systemic mastocytosis is suspected and has an impact on therapy or when cutaneous disease persists into adulthood.

1 January 2018 in Advances in Dermatology and Allergology
Verified
Journal Article
Open access
PDF file
JCJustyna Czarny
Justyna Czarny
MLMagdalena Lange
Magdalena Lange
HŁHanna Ługowska-Umer
Hanna Ługowska-Umer
Roman J. NowickiRoman J. Nowicki
Roman J. Nowicki
Mastocytosis is a rare myeloproliferative disease, characterized by excessive proliferation and accumulation of mast cells in the tissues. In cutaneous mastocytosis (CM), mast cells infiltration is limited to the skin, whereas in systemic mastocytosis (SM) internal organs are involved. The...

1 January 2017 in Dermatology Review
Verified
Journal Article
Open access
PDF file
JCJustyna Czarny
Justyna Czarny
MLMagdalena Lange
Magdalena Lange
MNMarek Niedoszytko
Marek Niedoszytko
BKBarbara Kwiecińska
Barbara Kwiecińska
AGAleksandra Maria Górska
Aleksandra Maria Górska
Roman J. NowickiRoman J. Nowicki
Roman J. Nowicki
Mastocytosis is a rare myeloproliferative disease caused by excessive proliferation and accumulation of mast cells in the skin and internal organs. The most common variant of mastocytosis in children is cutaneous mastocytosis. Systemic mastocytosis dominates in adults. Both CM and SM patients...

16 July 2026 in Eurosurveillance
Verified
Journal Article
Open access
DKDamian Kadylak
Damian Kadylak
MPMaciej Pastuszczak
Maciej Pastuszczak
JCJustyna Czarny
Justyna Czarny
MSMalgorzata Sokolowska-Wojdylo
Malgorzata Sokolowska-Wojdylo
Expression of concern 
BACKGROUND: While bacterial sexually transmitted infections (STIs) have increased across Europe over the past decade, Poland continuously reported the lowest notification rates in the European Union/European Economic Area (EU/EEA), raising concerns about under-ascertainment and diagnostic gaps. AIM: We describe national STI trends in Poland from 2013 to 2024, temporal changes around 2020 and subsequent years, and demographic and geographic patterns relevant for STI control. METHODS: We analysed aggregated statutory surveillance data for syphilis, gonorrhoea and C hlamydia trachomatis infections, and calculated annual incidence rates overall and by sex, age group and voivodeship. Temporal trends were assessed using year-over-year per cent change and average annual per cent change (AAPC) estimated from log-linear models. RESULTS: All three infections increased modestly before 2020, declined in 2020 and increased markedly thereafter. Between 2013 and 2024, incidence increased 2.7–3.8-fold. It was highest among men, young adults aged 20–34 years and in urbanised regions. By 2023, syphilis incidence reached 7.92 per 100,000 population in Poland compared with 9.9 per 100,000 in the EU/EEA, whereas gonorrhoea and chlamydia incidence remained substantially lower. National AAPC estimates were not statistically significant, although they increased in several demographic groups and voivodeships. CONCLUSION: Reported bacterial STI notifications in Poland are increasing, particularly among young adults and in urban regions. Persistently low gonorrhoea and chlamydia notification rates relative to EU/EEA levels probably reflect differences in diagnostic access and testing intensity rather than low transmission. Improving surveillance completeness, access to NAAT diagnostics, and testing coverage will be important to enhance detection and control.

1 January 2022 in Dermatology Review
Verified
Journal Article
Open access
PDF file
JCJustyna Czarny
Justyna Czarny
AOAdrianna Opalska-Tuszyńska
Adrianna Opalska-Tuszyńska
Introduction: False-positive treponemal tests can be obtained in patients with Lyme disease, but the coincidence of two spirochetal infections – early syphilis and Lyme disease – should also be considered. Objective: Our case illustrates that even though Lyme disease and early syphilis are...

18 May 2026 in BMC Infectious Diseases
Verified
Journal Article
Open access
DKDamian Kadylak
Damian Kadylak
JCJustyna Czarny
Justyna Czarny
MSMalgorzata Sokolowska-Wojdylo
Malgorzata Sokolowska-Wojdylo
Background: Lymphogranuloma venereum (LGV) caused by Chlamydia trachomatis serovars L1–L3 is increasingly reported among men who have sex with men (MSM) in Western Europe, yet appears to remain underrecognised in Central and Eastern Europe. We describe clinical characteristics, diagnostic pathways, and outcomes of LGV cases in Poland to highlight recognition barriers and public health implications. Methods: We conducted a retrospective case series of symptomatic MSM diagnosed with LGV at a dermatovenereology outpatient clinic in Gdańsk, Poland, between 1 December 2023 and 31 October 2025. Cases were confirmed by C. trachomatis nucleic acid amplification test followed by LGV-discriminatory PCR. We extracted demographic, clinical, laboratory, and treatment data from electronic records. Results: Seven MSM (median age 28 years, range 25–68) were diagnosed with LGV; five (71%) were living with HIV. Common symptoms included rectal bleeding, rectal pain, and mucopurulent discharge (each 71%). Median time from symptom onset to diagnosis was 6 months (range 2 weeks–7 months); patients consulted a median of 3 physicians (range 1–5) before diagnosis. Five underwent colonoscopy with findings initially suggesting inflammatory bowel disease or malignancy. Concurrent sexually transmitted infections were frequent, including gonorrhoea (57%), syphilis (29%), and herpes simplex virus (29%). All received doxycycline 100 mg twice daily for 21 days. Three patients—all with diagnostic delays ≥ 6 months—reported persistent anorectal symptoms post-treatment despite microbiological cure. Conclusions: LGV may be underdiagnosed in Poland, and diagnostic delays exceeding six months may be associated with persistent symptoms despite microbiological cure. Enhanced clinician awareness, routine sexual history-taking in both primary and specialist care, and improved access to LGV-discriminatory testing are needed to reduce morbidity and prevent irreversible complications in this vulnerable population.